Data / Form D filings / EXSULIN Corp
EXSULIN Corp: Form D filings
EXSULIN Corp, a biotechnology company in Burnsville, MN, filed 5 Form D notices with the SEC between 2009 and 2013. The latest, on August 8, 2013, reports $153,750 sold of a $4 million offering to 4 investors.
Find out what EXSULIN Corp does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2809 VALLEY VIEW ROAD, Burnsville, MN, 55306
- Phone
- (952) 898-5814
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1456348
The full lists. Form D filings in Minnesota: 692 rows, $34.60, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 8, 2013 | New notice | $4,000,000 | $153,750 | $3,846,250 | 4 | Jul 29, 2013 | sec.gov |
| May 30, 2012 | New notice | $4,000,000 | $350,000 | $3,650,000 | 1 | May 21, 2012 | sec.gov |
| Aug 23, 2010 | New notice | $1,000,000 | $100,000 | $900,000 | 1 | Aug 15, 2010 | sec.gov |
| Apr 15, 2010 | New notice | $1,500,000 | $120,000 | $1,380,000 | 1 | Apr 9, 2010 | sec.gov |
| Nov 20, 2009 | New notice | $300,000 | $300,000 | $0 | 1 | Oct 1, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Alexander Fleming | Executive Officer, Director, Promoter | |
| Scott Jones | Executive Officer, Director | |
| Lisa Jansa | Executive Officer, Director, Promoter |
Other biotechnology companies in Minnesota that filed recently
- Medical 21, Inc. $550,000 · Oct 23, 2026
- InSitu Biologics, Inc. $1.3 million · Oct 14, 2026
- Evia Bio, Inc. $5.5 million · Sep 28, 2026
- EyeMacular Regeneration, Inc. $2.9 million · Sep 25, 2026
- ProEncia Biotechnology Inc. $1.5 million · Aug 26, 2026
Every Form D from the week of Aug 5, 2013 · All recent filings in Minnesota · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what EXSULIN Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.